Funder: Alzheimer's Drug Discovery Foundation
Due Dates (Anticipated): February 2027 (Letter of Intent) | April 2027 (Full application)
Funding Amounts: Exploratory: up to ~$250,000; Proof-of-principle: up to ~$500,000; Validation: higher, based on scope—no strict cap; durations vary by project stage.
Summary: Supports development, validation, and translation of digital platforms (wearables, apps, sensors) for Alzheimer's disease detection and monitoring.
Key Information: Clinical collaboration required; both academic and for-profit applicants worldwide eligible; data sharing via Sage Bionetworks expected.